Skip to main content
Signal8
Becker Daniel J. profile photo

Daniel J. Becker

CIK: 0001752139

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Zura Bio Ltd logo
ZURA

Zura Bio Ltd

Director
ACELYRIN, Inc. logo
SLRN

ACELYRIN, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Zura Bio Ltd logo
    ZURA

    Zura Bio Ltd

    Jun 17, 2026
    Award(A)

    Share Option (Right to Buy)

    Direct
    51K shares-
  • Zura Bio Ltd logo
    ZURA

    Zura Bio Ltd

    May 29, 2025
    Award(A)

    Share Option (Right to Buy)

    Direct
    51K shares-
  • ACELYRIN, Inc. logo
    SLRN

    ACELYRIN, Inc.

    May 21, 2025
    Disposition(D)
    Direct
    3K shares-

1-3 of 3

About Becker Daniel J.

Becker Daniel J. (SEC CIK 0001752139) files insider reports with the SEC as Director of Zura Bio Ltd (ZURA) and Director of ACELYRIN, Inc. (SLRN).

Signal8 holds 4 ownership filings by Becker Daniel J. (1 Form 3, 3 Form 4), filed between May 23, 2025 and Jun 22, 2026. Those filings report 3 transactions, from May 21, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Becker Daniel J.'s filings is in HENDERSON, NV.

Recent filings by Becker Daniel J.

  • Jun 17, 2026: Grant or award of ZURA derivative securities (Form 4, code A).
  • May 29, 2025: Grant or award of ZURA derivative securities (Form 4, code A).
  • May 21, 2025: Disposition to issuer transaction of SLRN shares (Form 4, code D).

Other insiders filing for Zura Bio Ltd (ZURA)

How to read Form 4 transaction codes